LMAT - LeMaitre Vascular - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LMAT is currently covered by 5 analysts with an average price target of $87.9. This is a potential upside of $7.64 (9.52%) from yesterday's end of day stock price of $80.26.

LeMaitre Vascular's activity chart (see below) currently has 82 price targets and 74 ratings on display. The stock rating distribution of LMAT is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 98.42% with an average time for these price targets to be met of 269.45 days.

Highest price target for LMAT is $110, Lowest price target is $100, average price target is $94.25.

Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 28-Feb-2025. First documented stock forecast 24-Jun-2014.

Currently out of the existing stock ratings of LMAT, 12 are a BUY (80%), 3 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$93

2 months 12 days ago
(28-Feb-2025)

17/17 (100%)

$-1.73 (-1.83%)

151

Buy

$110

$31.3 (39.77%)

$75

2 months 12 days ago
(28-Feb-2025)

11/12 (91.67%)

$10.09 (10.10%)

265

Buy

$100

$21.3 (27.06%)

$75

6 months 9 days ago
(01-Nov-2024)

10/11 (90.91%)

$5.27 (5.56%)

156

Buy

$100

$21.3 (27.06%)

$13

11 months 9 days ago
(31-May-2024)

2/2 (100%)

$21.4 (27.23%)

105

Hold

$67

$-11.7 (-14.87%)

$70

1 years 9 months 7 days ago
(03-Aug-2023)

2/2 (100%)

$10.53 (18.65%)

552

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LMAT (LeMaitre Vascular) average time for price targets to be met?

On average it took 269.45 days on average for the stock forecasts to be realized with a an average price target met ratio 98.42

Which analyst has the current highest performing score on LMAT (LeMaitre Vascular) with a proven track record?

ANTHONY PETRONE

Which analyst has the most public recommendations on LMAT (LeMaitre Vascular)?

Anthony Petrone works at MIZUHO and has 15 price targets and 8 ratings on LMAT

Which analyst is the currently most bullish on LMAT (LeMaitre Vascular)?

Brooks O'neil with highest potential upside - $31.3

Which analyst is the currently most reserved on LMAT (LeMaitre Vascular)?

Chris Lewis with lowest potential downside - -$52.7

LeMaitre Vascular in the News

Why LeMaitre (LMAT) Shares Are Sliding Today

What Happened? Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) fell 12.2% in the afternoon session after the company reported weak first quarter 2025 results with a significant miss on full-year EPS guidance and underwhelming EPS guidance for next quarter. On the other hand, LeMaitre’s full-year revenue guidance topped analysts’ expectations and organic revenue outperform...

LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales

Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q1 CY2025 results beating Wall Street’s revenue expectations , with sales up 12% year on year to $59.87 million. Guidance for next quarter’s revenue was optimistic at $62.5 million at the midpoint, 2.2% above analysts’ estimates. Its GAAP profit of $0.48 per share was 4.6% below analysts’ consensus...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?